Viewing data from:

TENCON

ANDA

ACETAMINOPHEN; BUTALBITAL | A089405 | MALLINCKRODT CHEMICAL INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Tencon (2023)

Total Spending

$8K

Total Claims

225

Beneficiaries

Avg Cost/Unit

$0.65

Spending Trend

$27K(2019)→$15K(2020)→$12K(2021)→$11K(2022)→$8K(2023)

YoY Change:-2.4%

5yr CAGR:-2.7%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 650MG;50MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: May 15, 1990

No patent or exclusivity listings for this strength.